Accel-Rx Health Sciences Accelerator

Accel-Rx targets pre-seed and seed-stage health science ventures, often at the point of university spinout formation. It provides initial funding of up to CAD 500,000 per company and helps bridge to Series A rounds led by external venture capital firms.

The accelerator focuses exclusively on health sciences and life sciences. It does not invest in pure software, fintech, or consumer goods. Within health, it emphasizes therapeutics, diagnostics, medical devices, and digital health technologies with a clear path to regulatory approval or clinical adoption.

Accel-Rx is an independent nonprofit that partners with major Canadian research universities and hospital networks. It was established with support from the federal government's Networks of Centres of Excellence program and operates autonomously from any single university. Each hub maintains a formal affiliation with local academic institutions.